Background: This research aimed to provide an overview of the impact of adjuvant vaginal brachytherapy (VBT) and external beam pelvic radiotherapy (EBRT) with or without VBT on survival in stage I to II EC patients in China from a long-term multi-institutional analysis.
Methods: We retrospectively analyzed stage I to II EC patients from 13 institutions treated between 2003 and 2015. All patients underwent surgical staging and received adjuvant RT. Patients were divided into groups of low-risk (LR), intermediate-risk (IR), high-intermediate-risk (HIR) and high-risk (HR). Survival statistics, failure pattern, and toxicity of different radiation modalities in different risk groups were analyzed.
Results: A total of 1048 patients were included. HR disease represented 27.6%, HIR 17.7%, IR 27.7% and LR 27.1%, respectively. Endometrioid adenocarcinoma (EAC) and non-endometrioid carcinoma (NEC) accounted for 92.8 and 7.2%. A total of 474 patients received VBT alone and 574 patients received EBRT with or without VBT. As for EAC patients, the 5-year overall survival (OS), disease-free survival (DFS), local recurrence-free survival (LRFS), and distant metastasis-free survival (DMFS) rate was: 94.6, 90.4, 93.0 and 91.6%, respectively. For LR patients, EBRT (with or without VBT) seemed to be a risk factor. With the higher risk category, the survival benefit of EBRT gradually became remarkable. EBRT (with or without VBT) significantly increased DFS, LRFS and DMFS compared to VBT alone in the HR group (p < 0.05). Distant metastasis was the main failure pattern for all risk groups. As for NEC patients, the 5-year OS, DFS, LRFS and DMFS rate was: 93.4, 87.2, 91.7 and 89.3%, respectively. As for toxicity, EBRT (with or without VBT) significantly increased the incidence of grade 1-2 gastrointestinal, urinary, and hematological toxicity.
Conclusions: For stage I to II EC patients, EAC accounted for the majority and had better prognosis than NEC. For EAC patients, VBT alone resulted in comparable survival to EBRT in the LR, IR and HIR groups, while EBRT significantly increased survival in the HR group. EBRT had higher rate of toxicity than VBT.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919553 | PMC |
| http://dx.doi.org/10.1186/s12885-022-09343-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dosimetric comparison between single-channel vaginal cylinder and free-hand interstitial needles in vaginal brachytherapy of gynecological cancers.
J Contemp Brachytherapy
June 2024
Fujian Provincial Cancer Hospital, Jinan District, Fujian Province Fuzhou, 350014 Fuzhou City, China.
Article Synopsis
- - The study aimed to compare dosimetric outcomes of vaginal brachytherapy using two methods: single-channel vaginal cylinder (SCVC) and free-hand interstitial needles (FIN) in treating gynecologic tumors after surgery and external beam radiation therapy.
- - Out of 22 women treated, both methods achieved similar coverage of the high-risk clinical target volume (HR-CTV), but the FIN technique had better dose distribution and resulted in lower doses to critical organs like the rectum and bladder compared to SCVC.
- - The findings suggest that the FIN technique is a more effective option for high-dose-rate vaginal brachytherapy in minimizing radiation exposure to surrounding organs while ensuring adequate treatment coverage.
Clinical characteristics and radiation therapy modality of younger patients with early-stage endometrial cancer, a multicenter study in China's real world.
BMC Cancer
March 2024
Department of Radiation Oncology, The Second Hospital of Dalian Medical University, Dalian, People's Republic of China.
Background: Endometrial cancer is a prevalent gynecologic malignancy found in postmenopausal women. However, in the last two decades, the incidence of early-stage has doubled in women under 40 years old. This study aimed to investigate the clinical and pathological characteristics and adjuvant therapeutic modalities of both young and not -young patients with early-stage endometrial cancer in China's real world.
View Article and Find Full Text PDFRetrospective Analysis of All Types of Adjuvant Radiotherapy in Endometrial Cancer: Single-Center Experiences in a Middle-Income Country.
Asian Pac J Cancer Prev
February 2024
Division of Radiation Oncology, Faculty of Medicine, Chiang Mai University, Thailand.
Objective: We retrospectively analyzed the efficacy, focusing on overall survival (OS) and the patterns of failure, along with the toxicities of adjuvant radiotherapy (RT) in endometrial cancer patients.
Methods: Two-hundred and nineteen patients with endometrial cancer patients who received adjuvant radiotherapy ± adjuvant chemotherapy (ACT) from January 2014 to December 2018 were investigated for overall survival (OS), local recurrence-free survival rate (LRFS), regional recurrence-free survival rate (RRFS), and distant metastasis-free survival rate (DMFS).
Result: Two-hundred and fourteen patients were evaluated.
Effects of Adjuvant Radiation Plus Chemotherapy on Survival Outcomes in Stage III C Endometrial Cancer According to Histology: Analysis of Data from the Surveillance, Epidemiology, and End Results Database.
Technol Cancer Res Treat
November 2023
Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
To evaluate the survival benefit of radiation plus chemotherapy in adult females with stage IIIC endometrial cancer and to investigate whether the benefit varies according to histology. Data from adult females with International Federation of Gynecology and Obstetrics (FIGO) stage IIIC endometrial cancer, who underwent at least total hysterectomy between 2010 and 2015, were obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Adjuvant treatments were categorized as chemotherapy alone, chemotherapy with external beam radiation therapy (EBRT), chemotherapy with vaginal brachytherapy (VBT), or chemotherapy with EBRT+VBT.
View Article and Find Full Text PDFPractice patterns of adjuvant radiotherapy in women with stage I to II endometrial carcinoma: a real-world multi-institutional analysis in China.
BMC Womens Health
August 2023
Department of Radiation Oncology, The Second Hospital of Dalian Medical University, Dalian, People's Republic of China.
Article Synopsis
- The study analyzed postoperative radiotherapy practices for early-stage endometrial carcinoma patients across 13 Chinese medical centers between 2003 and 2017.
- A significant trend was observed where vaginal brachytherapy (VBT) became the primary treatment modality for low to intermediate-risk patients, while external beam pelvic radiotherapy (EBRT) continued to be used for high-risk patients.
- The research highlighted variability in VBT dose fractionation schedules and noted a transition from conventional radiotherapy to modern techniques like three-dimensional conformal and intensity-modulated radiotherapy during the study period.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!